Affiliations
AffiliationItem in Clipboard
The population's use of pharmaceuticalsC Metge et al. Med Care. 1999 Jun.
. 1999 Jun;37(6 Suppl):JS42-59. doi: 10.1097/00005650-199906001-00008. AffiliationItem in Clipboard
AbstractObjectives: In this study, population-based analysis is used to study the extent to which characteristics such as age, sex, socioeconomic status, and region of residence are associated with different patterns of pharmaceutical use. It also includes an examination of whether pharmaceutical use is responsive to differential health needs across the population.
Research design: Indicators of access, intensity of use, and total expenditures are used to describe Manitobans' use of pharmaceutical agents, consistent with the POPULIS framework.
Measures: Several rate-based measures have been developed for this purpose: the number of residents who are pharmaceutical users; the number of prescriptions dispensed; the number of different drugs dispensed; the total number of defined daily doses (DDDs) dispensed; and expenditures for pharmaceuticals. The DDD measurement provides a cumulative assessment of total drug use (i.e., across multiple drug categories) and is a useful indicator of a population's total drug exposure.
Results: Patterns of use of pharmaceuticals follow patterns similar to those patterns in earlier POPULIS studies on health care access, intensity, and expenditures. In areas where health is generally poorer, a greater number of prescriptions are dispensed. The highest use of pharmaceuticals also was found in the lower-income quintiles and among those at greatest socioeconomic risk, traditionally those with the poorest health status.
Conclusions: This kind of population-based pharmaceutical information can help monitor the effectiveness of policy initiatives, as well as serve to better manage pharmaceutical use within the health care system.
Similar articlesShanahan M, Steinbach C, Burchill C, Friesen D, Black C. Shanahan M, et al. Med Care. 1999 Jun;37(6 Suppl):JS60-82. doi: 10.1097/00005650-199906001-00009. Med Care. 1999. PMID: 10409018
Shanahan M, Gousseau C. Shanahan M, et al. Med Care. 1999 Jun;37(6 Suppl):JS83-100. doi: 10.1097/00005650-199906001-00010. Med Care. 1999. PMID: 10409019
Drozd M. Drozd M. Wiad Lek. 2002;55 Suppl 1(Pt 2):651-4. Wiad Lek. 2002. PMID: 17474578 Polish.
Roos NP, Black C, Roos LL, Frohlich N, DeCoster C, Mustard C, Brownell MD, Shanahan M, Fergusson P, Toll F, Carriere KC, Burchill C, Fransoo R, MacWilliam L, Bogdanovic B, Friesen D. Roos NP, et al. Med Care. 1999 Jun;37(6 Suppl):JS27-41. doi: 10.1097/00005650-199906001-00007. Med Care. 1999. PMID: 10409014 Review.
Roos NP. Roos NP. Med Care. 1999 Jun;37(6 Suppl):JS15-26. doi: 10.1097/00005650-199906001-00006. Med Care. 1999. PMID: 10409006 Review.
Weir DL, Motulsky A, Abrahamowicz M, Lee TC, Morgan S, Buckeridge DL, Tamblyn R. Weir DL, et al. Health Serv Res. 2020 Aug;55(4):512-523. doi: 10.1111/1475-6773.13292. Epub 2020 May 20. Health Serv Res. 2020. PMID: 32434274 Free PMC article.
Merrill RM, Telford CT. Merrill RM, et al. Prev Med Rep. 2018 Sep 11;12:158-163. doi: 10.1016/j.pmedr.2018.09.008. eCollection 2018 Dec. Prev Med Rep. 2018. PMID: 30263886 Free PMC article.
Leslie WD, MacWilliam L, Lix L, Caetano P, Finlayson GS. Leslie WD, et al. Osteoporos Int. 2005 Jul;16(7):773-82. doi: 10.1007/s00198-004-1756-5. Epub 2004 Oct 2. Osteoporos Int. 2005. PMID: 15580480
McAdam J, Bell EM. McAdam J, et al. Environ Health. 2023 May 10;22(1):41. doi: 10.1186/s12940-023-00992-x. Environ Health. 2023. PMID: 37161484 Free PMC article. Review.
McKay A, Katz A, Lipschitz J. McKay A, et al. Surg Endosc. 2013 Jul;27(7):2398-406. doi: 10.1007/s00464-012-2746-x. Epub 2013 Feb 27. Surg Endosc. 2013. PMID: 23443477
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3